Navigation Links
ORNL study reveals new characteristics of complex oxide surfaces

OAK RIDGE, Tenn., July 24, 2014 -- A novel combination of microscopy and data processing has given researchers at the Department of Energy's Oak Ridge National Laboratory an unprecedented look at the surface of a material known for its unusual physical and electrochemical properties.

The research team led by ORNL's Zheng Gai examined how oxygen affects the surface of a perovskite manganite, a complex material that exhibits dramatic magnetic and electronic behavior. The new avenue to understand surface behavior could benefit researchers who are interested in using a wide range of correlated oxide materials for applications such as solid fuel cells or oxygen sensors.

"Surface properties are key for any sensitive application, because the surface controls the interaction with the outside world," said coauthor Art Baddorf.

The team's results, published in Nature Communications, underscore why the materials are called "strongly correlated:" Because the chemical and physical functionalities are coupled, any minor change can influence the entire system.

"It's like the material has many knobs, and if you turn one, all the properties change," Gai said. "You turn a different knob and the whole thing changes again. It turns out the surface is another knob -- you can use it to change the properties."

The researchers used high-resolution scanning tunneling microscopy to generate images of the manganite surface -- down to the level of 30 picometers. A picometer is one trillionth of a meter. They then processed the imaging data to determine the position of each atom and calculate the angles between the atoms.

"Knowing where the atoms are positioned shows how they are interacting," Baddorf said.

The resulting "distortion maps" brought into view structural areas called domains that were not easily identified in the raw images. The maps clearly showed how the presence of oxygen atoms forced the atoms into a checkerboard pattern known as a Jahn-Teller distortion. Gai says the team's study is the first time the phenomenon has been observed on a material's surface.

"The oxygen totally changes the surface energy," Gai said. "Once you introduce oxygen, the electrons don't like to form a straight line; they zigzag to get to a lower energy state. This distortion is a very common concept in bulk materials, but nobody has been able to show this effect on the surface before."

The study is published as "Chemically induced JahnTeller ordering on manganite surfaces." Coauthors are ORNL's Wenzhi Lin, Paul Snijders, Thomas Ward, J. Shen, Stephen Jesse, Sergei Kalinin, and Arthur Baddorf; University of Nebraska's J.D. Burton and Evgeny Tsymbal; and IHI Corporation's K. Fuchigami.

This research was conducted in part at the Center for Nanophase Materials Sciences, a DOE Office of Science user facility. The DOE's Office of Science supported the research. Work at the University of Nebraska-Lincoln was supported by the National Science Foundation.


Contact: Morgan McCorkle
DOE/Oak Ridge National Laboratory

Related biology technology :

1. Positive Clinical Study Results for BSPs HyperQ Technology
2. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
3. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
4. Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver
5. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
6. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
7. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
8. Singapore scientists lead human embryonic stem cell study
9. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
10. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
11. Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination With Febuxostat
Post Your Comments:
Related Image:
ORNL study reveals new characteristics of complex oxide surfaces
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
(Date:11/24/2015)...  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General ... a.m. Israel time, at the law offices of ... 36 th Floor, Tel Aviv, Israel . ... Izhak Tamir to the Board of Directors; , election ... , approval of an amendment to certain terms of options granted to ...
Breaking Biology Technology:
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
(Date:11/9/2015)... , Nov. 09, 2015 ... addition of the "Global Law Enforcement ... offering. --> ) has ... Law Enforcement Biometrics Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
Breaking Biology News(10 mins):